Skip to main content

Table 2 Demographic, characteristic, damage index, and nephritis histopathology of juvenile systemic lupus erythematosus (JSLE) patients

From: Long noncoding RNAs (CTC-471J1.2, NeST) as epigenetic risk factors of active juvenile lupus nephritis: a case-control study

Parameter

JSLE patients (n = 61)

Age /y: (mean ± SD)

13.8 ± 2.56

Sex (Male / Female): N (%)

46 (75.4)/15 (24.6)

BMI: n (%)

 Underweight (Less than the 5th percentile)

1 (1.6)

 Normal (5th percentile to less than the 85th percentile)

43 (70.5)

 Overweight (85th percentile to less than the 95th percentile)

14 (23)

 Obese (95th percentile or greater)

3 (4.9)

Age of disease onset/y: (mean ± SD)

11.3 ± 2.29

Duration of disease/y: (median (range))

2 (0.1–7)

SLEDAI-2K: (median (range))

4 (0–21)

Disease activity status: n (%)

 High disease activity

21 (34.5)

 Low disease activity

32 (52.5)

 Inactive disease

8 (13)

SLICC/ACR-Damage Index: (median (range))

0 (0–0)

Nephritis: (mean ± SD)

3.03 ± 1.03

 Class I: n (%)

5 (8.2)

 Class II: n (%)

15 (24.6)

 Class III: n (%)

15 (24.6)

 Class IV: n (%)

25 (41)

 Class V: n (%)

1 (1.6)

Active lupus nephritis: n (%)

 No

45 (73.8)

 Yes

16 (26.2)

Activity index: (median (range))

6 (0–10)

Chronicity index: (median (range))

1 (0–4)

Renal SLEDAI: (median (range))

2 (0–16)

  1. Values reported as median (range), percentile, and mean ± SD
  2. Abbreviations: n Number, y Year, JSLE Juvenile systemic lupus erythematosus, BMI Bone mass index, SLEDAI Systemic Lupus Erythematosus Disease Activity Index, SLICC/ACR damage index Systemic Lupus International Collaborating Clinics/American Colleague of Rheumatology